Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources. Under construction and review—see the updates log.

Evidence Library

Filter by drug, type, year, and open access.

Drug

Type

Year ≥

Sort

Open access

Active filters:

Showing 1–4 of 4 results

Vanda Pharmaceuticals announces FDA approval of BYSANTI (milsaperidone) for schizophrenia and bipolar I disorder — Vanda Pharmaceuticals (press release) (2026)• Drug: milsaperidoneOpen access
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia — American Psychiatric Association (2020)• Drug: milsaperidone
Iloperidone for schizophrenia: updated systematic review and meta-analysis — International Journal of Neuropsychopharmacology (2019)• Drug: milsaperidoneDOI PMID
CANMAT and ISBD 2018 guidelines for the management of patients with bipolar disorder — Bipolar Disorders (2018)• Drug: milsaperidoneDOI